Search hospitals > California > Los Angeles
University of California, Los Angeles
Claim this profileLos Angeles, California 90095
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Pancreatic Cancer
Conducts research for Prostate Cancer
Conducts research for Breast Cancer
1327 reported clinical trials
145 medical researchers
Summary
University of California, Los Angeles is a medical facility located in Los Angeles, California. This center is recognized for care of Cancer, Lung Cancer, Pancreatic Cancer, Prostate Cancer, Breast Cancer and other specialties. University of California, Los Angeles is involved with conducting 1,327 clinical trials across 1,496 conditions. There are 145 research doctors associated with this hospital, such as Jacqueline N. Casillas, Zev A. Wainberg, Gary Schiller, MD, and Theodore Moore, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
FGFR3 positive
2Lung Cancer
Global LeaderStage IV
Stage III
MET positive
Top PIs
Jacqueline N. CasillasMiller Children's and Women's Hospital Long Beach8 years of reported clinical research
Expert in Cancer
Expert in Brain Tumor
48 reported clinical trials
97 drugs studied
Zev A. WainbergUCLA3 years of reported clinical research
Expert in Pancreatic Cancer
Expert in Solid Tumors
33 reported clinical trials
65 drugs studied
Gary Schiller, MDUCLA Medical Center7 years of reported clinical research
Expert in Acute Myelogenous Leukemia
Expert in Acute Myeloid Leukemia
31 reported clinical trials
52 drugs studied
Theodore Moore, MDMattel Children's Hospital UCLA8 years of reported clinical research
Studies Cancer
Studies Brain Tumor
21 reported clinical trials
59 drugs studied
Clinical Trials running at University of California, Los Angeles
Cancer
Non-Hodgkin's Lymphoma
Bladder Cancer
Lymphoma
Coronavirus
B-Cell Lymphoma
Autism Spectrum Disorder
Stroke
Idiopathic Pulmonary Fibrosis
Glioblastoma
Abatacept
for Myocarditis
This Trial tests if abatacept can reduce serious heart problems in patients with heart inflammation caused by cancer treatments. Abatacept calms the immune system by preventing certain immune cells from becoming fully active, reducing inflammation and damage. Abatacept has been approved by the US Food and Drug Administration for the treatment of rheumatoid arthritis, with or without methotrexate.
Recruiting3 awards Phase 311 criteria
Telisotuzumab Vedotin vs. Docetaxel
for Non-Small Cell Lung Cancer
This trial is testing a new drug called telisotuzumab vedotin to see if it can treat a specific type of lung cancer better than an existing drug. The study focuses on adults whose lung cancer has not responded to previous treatments. The new drug targets and kills cancer cells by attaching to a specific protein on their surface.
Recruiting2 awards Phase 312 criteria
Personalized Radiotherapy
for Head and Neck Cancer
This trial tests how well personalized ultra fractionated stereotactic adaptive radiotherapy (PULSAR) works together with HyperArc© radiation treatment planning technology for palliative (holistic pain and symptom control) tumor control in patients with primary or recurrent, localized or metastatic head and neck cancer (HNC) who are ineligible for or decline standard of care treatment. Researchers want to evaluate if using HyperArc and PULSAR together will deliver higher, possibly more effective doses, resulting in better tumor control with the same or fewer side effects than smaller routine doses. PULSAR is a radiation therapy regimen that uses a limited number of fairly large dose pulses while adjusting to specific anatomic and/or biological changes which may occur during the course of the treatment. HyperArc radiation treatment planning technology is a tool that allows for target dose escalation to tumor tissue while maintaining minimal head and neck organs-at-risk doses compared to other radiation treatment planning software. Undergoing PULSAR and HyperArc technology together may be a safe and effective palliative treatment option for patients with HNC.
Recruiting1 award N/A6 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of California, Los Angeles?
University of California, Los Angeles is a medical facility located in Los Angeles, California. This center is recognized for care of Cancer, Lung Cancer, Pancreatic Cancer, Prostate Cancer, Breast Cancer and other specialties. University of California, Los Angeles is involved with conducting 1,327 clinical trials across 1,496 conditions. There are 145 research doctors associated with this hospital, such as Jacqueline N. Casillas, Zev A. Wainberg, Gary Schiller, MD, and Theodore Moore, MD.
Where is University of California, Los Angeles located?
**Directions to UCLA Hospital, Los Angeles:**
- Take the San Diego Freeway (405) to Wilshire Boulevard East.
- Turn left on Westwood Blvd and continue past Le Conte Avenue.
- The hospital is located on the left, past UCLA Medical Plaza.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at UCLA Hospital, contact the Patient Business Services Office at 310-825-8021, available Monday through Friday, 8:30 am to 4:00 pm. They offer support with the Financial Assistance Program, including eligibility, application process, and discounts for qualifying patients. Assistance with insurance coverage and billing questions is also available.
What insurance does University of California, Los Angeles accept?
The University of California, Los Angeles (UCLA) accepts a variety of insurance plans, including:
1. **UC-sponsored medical plans**: Designed to meet the health care and insurance needs of UCLA employees and their families.
2. **Blue Shield Exclusive PPO Network**: Available through Covered California for 2023.
3. **Cigna + Oscar - Open Access Plus**: For small businesses, accessible through Covered California.
4. **L.A. Care Health Plan Covered California**: Offered through Covered California.
5. **UC Care**: A PPO plan for UC employees and retirees not enrolled in Medicare, managed by Anthem Blue Cross (medical) and Navitus (pharmacy).
6. **UC Student Health Insurance Plan (UC SHIP)**: A systemwide plan providing enhanced health benefits to all enrolled students.
Please verify with the specific department or service at UCLA to confirm the acceptance of your insurance plan.
What awards or recognition has University of California, Los Angeles received?
The University of California, Los Angeles (UCLA) hospital is ranked third on the national honor roll and has been recognized as one of America's Best Hospitals for 21 consecutive years. It boasts top 10 national rankings in 12 specialties, including cancer, neurology and neurosurgery, orthopedics, and pulmonology and lung surgery. The David Geffen School of Medicine at UCLA received $303 million in funding from the National Institutes of Health for 2023-24, highlighting its significant research efforts.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.